CAR T-Cell Therapy: Expert Guidance for Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

1.00
A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Evolving CLL Treatment Recommendations

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Assessing Measurable Residual Disease in Chronic Lymphocytic Leukemia

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Addressing Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Evolution in Expert Recommendations for CLL Treatment

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Measurable Residual Disease Assessment in Chronic Lymphocytic Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Clinical and Guideline Updates on Systemic Therapies for Hepatocellular Carcinoma

Content Format:

Video

Credit Type:

ACPE

Credits:

1.00
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Biomarkers in Gastrointestinal Cancer: Expert Perspectives and Guidance for Individualized Treatment

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Multidisciplinary Perspectives on CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Multidisciplinary Perspectives on Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Key Studies in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: Independent Conference Coverage of the 2021 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Biomarkers in Gastrointestinal Cancer: Applying the Latest Data in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Applying Current Evidence on Tailored Therapeutic Strategies to Improve Outcomes for Patients With Myeloproliferative Neoplasms

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
State-of-the-Art Biomarker Testing in Gastrointestinal Cancer: Guidance for Oncologists and Pathologists

Content Format:

Multimedia

Credit Type:

ABIM MOC | AMA

Credits:

1.25
CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Addressing Evolving Educational Needs on BTK Inhibitor Therapies in CLL/SLL and MCL

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Choosing Frontline Therapy in Chronic Lymphocytic Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Biomarkers in Gastrointestinal Cancer: Evidence-Based Treatment in the Precision Medicine Era

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Advances in CAR-T Cell Therapy Across Hematologic Malignancies: From Pipeline to Clinical Practice

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.25
What Pharmacists Should Know About CAR T-Cell Therapy

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.25
Understanding CAR T-Cell Therapy: Guidance for Current Clinic and Future Directions

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.00
A Global Perspective on Biomarkers in Gastrointestinal Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.25
Conference to Clinic: Recent Advances in Biomarker-Driven Treatment of GI Cancers

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Immune Checkpoint Inhibitors: Altering the Landscape of Treatment in Hepatobiliary Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the 2021 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

0.75
Medical Minute: Recently Approved HER2 and TROP2 Agents: Pharmacist Considerations

Content Format:

Multimedia

Credit Type:

ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25
Current and Emerging CAR T-Cell Therapies in Cancer Care

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Medical Minute: Recent Advances in HER2-, HER3-, and TROP2-Targeted Therapies for Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
Immunotherapy Approaches for HCC

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
CAR T-Cell Therapy: Optimizing Collaboration, Referral, Treatment, and Follow-up to Improve Outcomes

Content Format:

Case Challenge

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
MedicalMinute: Identifying and Managing CAR T-Cell–Mediated Toxicities

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Supportive Care Considerations for CAR T-Cell Therapy: Establishing Standards of Care With the Multidisciplinary Team

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Guiding Patients and Caregivers Starting CAR T-Cell Therapy

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Recent Advances in Targeting HER2 and HER3 in Metastatic Gastrointestinal Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.50
MedicalMinute: Current and Near-Future CAR T-Cell Therapy Indications

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Immunotherapy for Advanced HCC: Case Series

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
MedicalMinute: Recent Advances With Antibody–Drug Conjugates Targeting HER2, HER3, and TROP2 in Lung Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Immune Checkpoint Inhibitors for Hepatobiliary Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.25
Current and Emerging Clinical Strategies for Pancreatic Cancer Treatment

Content Format:

Multimedia

Credit Type:

--

Credits:

--
The Emerging Role of PARP Inhibitors in the Maintenance Setting for Patients With Advanced Pancreatic Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Neoadjuvant and Adjuvant Therapy Strategies for Patients With Resectable Pancreatic Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Key Studies in Lymphomas: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Current Therapeutic Options for Metastatic Pancreatic Cancer: Second-line Treatment

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Current Therapeutic Options for Metastatic Pancreatic Cancer: First-line Treatment

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Critical Advances in Systemic Therapy for HCC: Building on Recent Progress for Community Practices

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
An Expert Overview of Immunotherapy for Advanced HCC

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.25
MedicalMinute: Assessment of HER2 Status and Targeting HER2 and HER3 in Gastrointestinal Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
An Overview of HER2, HER3, and TROP2 Testing and Targeted Treatment in Breast and GI Cancers

Content Format:

Multimedia

Credit Type:

ABPath MOC | AMA

Credits:

0.75
Immunotherapy for Advanced HCC: Experts Answer Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.25
MedicalMinute: Expert Answers to Key Questions in HER2 Testing in Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
MedicalMinute: Coordinating Care in the Community Setting to Improve Adherence to HER2 Testing Recommendations for MBC

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Clinical Advances in Immune Thrombocytopenia: Integrating New Therapies

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.50
A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Immunotherapy for HCC: Current Evidence and Future Directions

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
MedicalMinute: Selecting Novel HER2- and TROP2-Targeted Therapeutics for Patients With Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Assessment of HER2 Status and Targeting HER2 in Gastrointestinal Cancers

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

0.75
Applying The Results of Practice-Changing Clinical Research To Patient Care in Hepatocellular Carcinoma

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Cases in CLL: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Options for an Older Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Patient Progressing on BR With Subsequent Ibrutinib Intolerance

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Targeting HER2, HER3 and TROP2 in Breast Cancer

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

0.75
Cases in CLL: High-Risk Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Fit, Younger Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Second-Line Therapy Following Chemoimmunotherapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Diagnostic Testing for HER2, HER3, and TROP2 and Treatment Implications in Metastatic Breast Cancer

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

1.25
Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Content Format:

Video

Credit Type:

--

Credits:

--
Advances in the Treatment of Pancreatic Cancer: Nursing Education to Optimize Clinical Practice

Content Format:

Video

Credit Type:

--

Credits:

--
CAR T-Cell Therapy: Applying the Data, Tailoring Treatment, and Future Considerations

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
The Treatment Journey With CAR T-Cell Therapy: Recommendations for Care Teams, Patients, and Caregivers

Content Format:

Video

Credit Type:

ANCC

Credits:

2.00
Bispecific Antibodies in Multiple Tumor Types

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Incorporating Recent Advances in the Treatment of MPNs Into Clinical Practice

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
New Insights in Hematologic Malignancies and Disorders: Independent Conference Coverage of the 2019 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Community Oncology Best Practices in CAR T-Cell Therapy

Content Format:

Case Challenge

Credit Type:

ACPE | AMA

Credits:

1.00
ASCO GI 2020: Expert Thoughts on Key Studies

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.50
Expert Guidance Frequently Asked Questions About CAR T-Cell Therapy in the Community Setting

Content Format:

Text Module

Credit Type:

--

Credits:

--
My Take on Key Studies in CAR T-Cell Therapy From ASH 2019

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Advances in CAR T-Cell Therapy for Leukemia, Lymphoma, and Myeloma: Where We Are and Where We Are Going

Content Format:

Case Challenge

Credit Type:

AMA

Credits:

2.25
Approaches to Individualized Management of Patients with Myeloproliferative Neoplasms: Best Practices and Guidance to Optimize Care

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.50
Incorporating the Latest Therapeutic Strategies for HCC: Collaborating to Optimize Patient Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Preview of ASH 2019: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

1.00
The Evolving Role of VEGF Targeted Agents in Treating Solid Tumors

Content Format:

Text Module

Credit Type:

--

Credits:

--
Navigating a New Therapeutic Era for HCC: Expert Review of New Agents and Guideline Recommendations

Content Format:

Video

Credit Type:

--

Credits:

--
Exploring New Treatment Strategies for Immune Checkpoint Blockade in Melanoma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Expert Perspective on Implementing HCV Treatment as Prevention in At-Risk European Populations

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Moving Toward a Cure for More Patients With Hodgkin Lymphoma: Expert Guidance and Practical Case Discussions

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.25
Management of Initial and Recurrent C. difficile Infections

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75